Related Experiment Video
Updated: Aug 10, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
A novel variant of COL6A3 c.6817-2(IVS27)A>G causing Bethlem myopathy: A case report
Maohua Li1, Jiandi Huang1, Min Liu1
1Department of Neurology, The Second Affiliated Hospital (Xinqiao Hospital), Army Medical University (Third Military Medical University), Chongqing, China.
Abstract:
Bethlem myopathy (BM) is a disease that is caused by mutations in the collagen VI genes. It is a mildly progressive disease characterized by proximal muscle weakness and contracture of the fingers, the wrist, the elbow, and the ankle. BM is an autosomal dominant inheritance that is mainly caused by dominant COL6A1, COL6A2, or COL6A3 mutations. However, a few cases of collagen VI mutations with bilateral facial weakness and Beevor's sign have also been reported. This study presents a 50-year-old female patient with symptoms of facial weakness beginning in childhood and with the slow progression of the disease with age. At the age of 30 years, the patient presented with asymmetrical proximal muscle weakness, and the neurological examination revealed bilateral facial weakness and a positive Beevor's sign. Phosphocreatine kinase was slightly elevated with electromyography showing myopathic changes and magnetic resonance imaging (MRI) of the lower limb muscles showing the muscle MRI associated with collagen VI (COL6)-related myopathy (COL6-RM). The whole-genome sequencing technology identified the heterozygous mutation c.6817-2(IVS27)A>G in the COL6A3 gene, which was in itself a novel mutation. The present study reports yet another case of BM, which is caused by the recessive COL6A3 intron variation, widening the clinical spectrum and genetic heterogeneity of BM.
Insights
Bethlem myopathy, a collagen VI-related myopathy, can be caused by novel recessive COL6A3 gene mutations. This case highlights the genetic diversity of Bethlem myopathy, expanding its known clinical and genetic spectrum.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Bethlem myopathy (BM) is a collagen VI-related myopathy (COL6-RM) characterized by progressive muscle weakness and contractures.
- Typically inherited in an autosomal dominant pattern, mutations in COL6A1, COL6A2, or COL6A3 genes are implicated.
- While rare, some COL6 mutations present with facial weakness and Beevor's sign.
Observation:
- A 50-year-old female patient exhibited childhood-onset facial weakness and progressive, asymmetrical proximal muscle weakness starting at age 30.
- Neurological examination revealed bilateral facial weakness and a positive Beevor's sign.
- Electromyography showed myopathic changes, and MRI confirmed muscle alterations consistent with COL6-RM.
Findings:
- Whole-genome sequencing identified a novel heterozygous mutation, c.6817-2(IVS27)A>G, in the COL6A3 gene.
- This specific mutation was found to be a recessive intron variation.
- The findings indicate a new genetic cause for Bethlem myopathy.
Implications:
- This case expands the known genetic heterogeneity of Bethlem myopathy.
- It broadens the clinical spectrum of COL6-RM, including recessive inheritance patterns.
- Understanding these novel mutations is crucial for accurate diagnosis and genetic counseling in collagen VI-related myopathies.
More Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Point and Frameshift Mutations
Incomplete Dominance
Histone Variants at the Centromere
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

